Skip to content
10-K

Annual Report

NEUROPATHIX, INC.

0001607062-22-000284

← back to feed
Filed
Apr 15, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Apr 15, 2022 93.37M sh
Capex FY 2021 · Dec 31, 2021 $6.52K
Capex FY 2021 · Dec 31, 2020 $0
Operating Cash Flow FY 2021 · Dec 31, 2021 −$889.64K
Operating Cash Flow FY 2021 · Dec 31, 2020 −$944.2K
Long Term Debt FY 2021 · Dec 31, 2021 $107.91K
Long Term Debt FY 2021 · Dec 31, 2020 $950K
Short Term Debt FY 2021 · Dec 31, 2021 $42.09K
Short Term Debt FY 2021 · Dec 31, 2020 $42.09K
Cash And Equivalents FY 2021 · Dec 31, 2021 $15.68K
Cash And Equivalents FY 2021 · Dec 31, 2020 $21.87K
Stockholders Equity FY 2021 · Dec 31, 2021 −$3.99M
Stockholders Equity FY 2021 · Dec 31, 2020 −$3.19M
Stockholders Equity FY 2021 · Dec 31, 2019 −$1.69M
Current Liabilities FY 2021 · Dec 31, 2021 $2.98M
Current Liabilities FY 2021 · Dec 31, 2020 $2.55M
Total Liabilities FY 2021 · Dec 31, 2021 $4.21M
Total Liabilities FY 2021 · Dec 31, 2020 $3.45M
Current Assets FY 2021 · Dec 31, 2021 $138.39K
Current Assets FY 2021 · Dec 31, 2020 $183.27K
Total Assets FY 2021 · Dec 31, 2021 $224.7K
Total Assets FY 2021 · Dec 31, 2020 $259.66K
Sga Expense FY 2021 · Dec 31, 2021 $2.67M
Sga Expense FY 2021 · Dec 31, 2020 $3.38M
Rd Expense FY 2021 · Dec 31, 2021 $451.78K
Rd Expense FY 2021 · Dec 31, 2020 $1.1M
Net Income FY 2021 · Dec 31, 2021 −$3.56M
Net Income FY 2021 · Dec 31, 2020 −$4.54M
Operating Income FY 2021 · Dec 31, 2021 −$2.94M
Operating Income FY 2021 · Dec 31, 2020 −$4.47M
Revenue FY 2021 · Dec 31, 2021 $183.48K
Revenue FY 2021 · Dec 31, 2020 $0